BiomX (PHGE) Return on Assets (2019 - 2026)

BiomX (PHGE) posted Return on Assets of 0.04% for Q1 2026, down 1147.08% sequentially from 0.0% in Q4 2025, and down 4.0% YoY from 0.04% in Q1 2025.

BiomX (PHGE) Return on Assets (2019 - 2026) Analysis & Trends

BiomX has reported Return on Assets for 8 years, with the latest figure at 0.04% in Q1 2026.

Quarterly Return on Assets fell 4.0% year-over-year to 0.04% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.04% (down 4.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
Return on Assets fell to 0.04% in Q1 2026 per PHGE's latest filing, from 0.0% in the prior quarter.
Over five years, Return on Assets peaked at 0.0% in Q4 2024 and troughed at 0.04% in Q1 2026.
A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Assets.
The sharpest annual moves came in 2024 and 2026: Return on Assets rose 1 bps in 2024, then decreased 4 bps in 2026.
Over 5 years, Return on Assets stood at 0.0% in 2022, then slumped by 522 bps to 0.01% in 2023, then surged by 153 bps to 0.0% in 2024, then slumped by 160 bps to 0.0% in 2025, then slumped by 1147 bps to 0.04% in 2026.
According to Business Quant data, Return on Assets over the past three periods registered 0.04%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROA (Qtr)
1	Vertex Pharmaceuticals	139.69 Bn	131.84 Bn	2.84 Bn	0.00%
2	Regeneron Pharmaceuticals	86.46 Bn	78.47 Bn	3.93 Bn	0.00%
3	Argenx Se	65.62 Bn	60.44 Bn	1.37 Bn	-
4	Moderna	58.37 Bn	53.24 Bn	52.00 Mn	0.00%
5	BeOne Medicines	42.17 Bn	37.07 Bn	1.53 Bn	0.00%
6	Alnylam Pharmaceuticals	31.73 Bn	28.43 Bn	992.69 Mn	0.00%
7	BioNTech SE	28.27 Bn	9.87 Bn	668.28 Mn	0.00%
8	Insmed	27.58 Bn	26.42 Bn	358.27 Mn	0.00%
9	Royalty Pharma	27.23 Bn	26.40 Bn	-	0.00%
10	BiomX	359,064.97	-808,935.03	-	-0.09%

Download Data